Simplex Trading’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $626K | Sell |
1,401
-2,110
| -60% | -$984K | ﹤0.01% | 3015 |
|
|
2025
Q4 | $1.59M | Buy |
3,511
+1,908
| +119% | +$822K | ﹤0.01% | 2170 |
|
|
2025
Q3 | $627K | Buy |
+1,603
| New | +$670K | ﹤0.01% | 3553 |
|
|
2024
Q2 | – | Sell |
-11,435
| Closed | -$4.96M | – | 9937 |
|
|
2024
Q1 | $4.78M | Buy |
+11,435
| New | +$4.83M | ﹤0.01% | 1636 |
|
|
2023
Q4 | – | Sell |
-10,573
| Closed | -$3.91M | – | 9938 |
|
|
2023
Q3 | $3.68M | Buy |
10,573
+10,273
| +3,424% | +$3.59M | ﹤0.01% | 1552 |
|
|
2023
Q2 | $105K | Sell |
300
-9,490
| -97% | -$3.2M | ﹤0.01% | 5033 |
|
|
2023
Q1 | $3.08M | Buy |
9,790
+9,224
| +1,630% | +$2.77M | ﹤0.01% | 1609 |
|
|
2022
Q4 | $163K | Buy |
566
+216
| +62% | +$65.8K | ﹤0.01% | 4490 |
|
|
2022
Q3 | $101K | Sell |
350
-11,551
| -97% | -$3.32M | ﹤0.01% | 5520 |
|
|
2022
Q2 | $3.35M | Buy |
11,901
+6,589
| +124% | +$1.76M | ﹤0.01% | 1407 |
|
|
2022
Q1 | $1.39M | Sell |
5,312
-8,253
| -61% | -$1.96M | ﹤0.01% | 2502 |
|
|
2021
Q4 | $2.98M | Buy |
13,565
+4,265
| +46% | +$829K | ﹤0.01% | 1640 |
|
|
2021
Q3 | $1.88M | Sell |
9,300
-40
| -0.4% | -$7.81K | ﹤0.01% | 2231 |
|
|
2021
Q2 | $1.88M | Sell |
9,340
-8,714
| -48% | -$1.82M | ﹤0.01% | 2250 |
|
|
2021
Q1 | $3.88M | Sell |
18,054
-8,094
| -31% | -$1.78M | 0.01% | 1020 |
|
|
2020
Q4 | $0 | Buy |
26,148
+20,582
| +370% | +$4.72M | ﹤0.01% | 9160 |
|
|
2020
Q3 | $0 | Buy |
5,566
+4,179
| +301% | +$1.15M | ﹤0.01% | 8607 |
|
|
2020
Q2 | $0 | Buy |
+1,387
| New | +$376K | ﹤0.01% | 8448 |
|
|
2020
Q1 | – | Sell |
-1,838
| Closed | -$422K | – | 8356 |
|
|
2019
Q4 | $402K | Buy |
+1,838
| New | +$372K | ﹤0.01% | 2964 |
|
|
2018
Q4 | – | Sell |
-10,342
| Closed | -$1.79M | – | 7901 |
|
|
2018
Q3 | $1.99M | Buy |
10,342
+8,430
| +441% | +$1.5M | 0.01% | 1252 |
|
|
2018
Q2 | $324K | Sell |
1,912
-1,911
| -50% | -$296K | ﹤0.01% | 2925 |
|
|
2018
Q1 | $623K | Buy |
+3,823
| New | +$624K | 0.03% | 609 |
|
|
2017
Q3 | – | Sell |
-25,865
| Closed | -$3.89M | – | 6720 |
|
|
2017
Q2 | $3.33M | Buy |
+25,865
| New | +$3.11M | 0.14% | 113 |
|
|
2016
Q4 | – | Sell |
-8,368
| Closed | -$681K | – | 6600 |
|
|
2016
Q3 | $729K | Buy |
8,368
+4,449
| +114% | +$420K | 0.05% | 358 |
|
|
2016
Q2 | $337K | Buy |
3,919
+1,969
| +101% | +$170K | 0.02% | 715 |
|
|
2016
Q1 | $155K | Sell |
1,950
-273
| -12% | -$24.7K | 0.01% | 1033 |
|
|
2015
Q4 | $279K | Sell |
2,223
-940
| -30% | -$113K | 0.02% | 678 |
|
|
2015
Q3 | $329K | Sell |
3,163
-330
| -9% | -$42.4K | 0.02% | 633 |
|
|
2015
Q2 | $431K | Sell |
3,493
-8,188
| -70% | -$1.03M | 0.04% | 442 |
|
|
2015
Q1 | $1.38M | Buy |
+11,681
| New | +$1.4M | 0.16% | 125 |
|
Other funds holding VRTX
VCM
VPM
Simplex Trading's VRTX Position: Q1 2026 in Review
Simplex Trading reduced its Vertex Pharmaceuticals (VRTX) stake by 60% in Q1 2026, selling an estimated $984K and leaving 1,401 shares worth $626K. The position accounts for ﹤0.01% of the portfolio, ranked #3015.
Simplex Trading first reported a position in VRTX in Q1 2015 and has held it in 30 quarters since. The position peaked at $4.78M in Q1 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Simplex Trading held 1,401 shares of Vertex Pharmaceuticals worth $626K as of Q1 2026.
- Simplex Trading sold 2,110 Vertex Pharmaceuticals shares in Q1 2026, an estimated $984K.
- Vertex Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #3015 holding.
- Simplex Trading first reported a position in Vertex Pharmaceuticals in Q1 2015 and has held it in 30 quarters since.
- Simplex Trading's Vertex Pharmaceuticals position peaked at $4.78M in Q1 2024.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.